Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumoursTeresa Gelardi, Claudia De Lorenzo|British Journal of Cancer|2010Cited by 39
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapyChiara D’Avino, Claudia De Lorenzo|Oncotarget|2016Cited by 25
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2Margherita Passariello, Claudia De Lorenzo|Scientific Reports|2021Cited by 21
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor EfficacyMargherita Passariello, Claudia De Lorenzo|International Journal of Molecular Sciences|2022Cited by 10